Related Experiment Video
Updated: Oct 11, 2025

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
Published on: August 2, 2021
Health care utilisation in treatment-resistant depression: a Swedish population-based cohort study
Philip Brenner1, Adam Nygren1, David Hägg1
1Centre for Pharmacoepidemiology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Patients with treatment-resistant depression (TRD) experience significantly higher healthcare utilization, including inpatient days and outpatient visits, compared to those without TRD. This elevated need for care persists for over three years, indicating a substantial burden.
Area of Science:
- Psychiatry and Mental Health
- Health Services Research
- Epidemiology
Background:
- Depression is a leading cause of disability worldwide.
- Treatment-resistant depression (TRD) affects a significant proportion of individuals with depression, posing challenges for effective management.
- Understanding the healthcare utilization (HCU) patterns in TRD is crucial for resource allocation and patient support.
Purpose of the Study:
- To compare the health care utilisation (HCU) of patients diagnosed with treatment-resistant depression (TRD) against those with depression not meeting TRD criteria.
- To quantify differences in inpatient and outpatient care frequency between TRD and non-TRD depression cohorts.
Main Methods:
- A nationwide Swedish register-based prospective cohort study was conducted.
- 16,329 patients aged 18-69 with incident depression and antidepressant treatment were identified and defined as TRD upon the third distinct consecutive treatment episode.
- Each TRD patient was matched with five comparators; HCU (inpatient days, outpatient visits) was assessed, with a focus on depression or suicide attempt as the main diagnosis.
Main Results:
- Patients with TRD exhibited substantially higher all-cause inpatient care risk (first year aRR 3.03) compared to controls.
- The disparity was more pronounced for depression as a main diagnosis (first year aRR 4.41) and after suicide attempts (first year aRR 4.43).
- TRD patients also had more frequent outpatient visits (first year aRR 2.05), with elevated HCU persisting throughout the follow-up period.
Conclusions:
- Patients with treatment-resistant depression demonstrate a two- to fourfold increase in healthcare utilisation across various measures.
- This elevated HCU for TRD patients is sustained over an extended period, suggesting increased healthcare costs and patient burden.
- The findings highlight the significant impact of TRD on healthcare systems and the need for targeted interventions and support.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Psychosis: Goals of Pharmacotherapy
Depressive Disorders: MDD and Dysthymia
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Electroconvulsive Therapy
Long-term Depression
Calcium Ion Concentration Mechanism
If over...

